Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2021-08-09 00:00:00 ET · period of report 2021-08-05 · accession 0001735276-21-000079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-09 | 2021-08-05 | ALNY | KEATING LAURIE | EVP, CLO | M - OptEx | $88.95 | +10.0K | 15.1K | +195% | +$889.5K |
| D | 2021-08-09 | 2021-08-05 | ALNY | KEATING LAURIE | EVP, CLO | S - Sale+OE | $188.95 | -10.0K | 5,132 | -66% | -$1.89M |
| DM | 2021-08-09 | 2021-08-05 | ALNY | KEATING LAURIE | EVP, CLO | M - OptEx | $0.00 | -10.0K | 1,124 | -90% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-05 | M | A | 7,876 | $88.95 | 13,008 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-05 | M | A | 2,124 | $88.95 | 15,132 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-05 | S | D | 10,000 | $188.95 | 5,132 | D | — | — | |
| 4 | Derivative | Performance Stock Option 2015 (right to buy) | 2021-08-05 | M | D | 2,124 | $0.00 | 11,876 | D | $88.95 · 2019-08-06 to 2025-12-18 | 2,124 Common Stock | |
| 5 | Derivative | Stock Option (right to buy) | 2021-08-05 | M | D | 7,876 | $0.00 | 1,124 | D | $88.95 · — to 2025-12-18 | 7,876 Common Stock | (F3) The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter. |